|
ECT-001-CB Clinical Trials
1 actively recruiting trial
Pipeline
Phase 1/2: 1
Top Sponsors
- Ciusss de L'Est de l'Île de Montréal1
Indications
- Hematologic Malignancy Requiring an Allogeneic Hematopoietic Stem Cell Transplant Lacking a Donor1
- Myelodysplastic Syndromes, High Risk1
- Acute Leukemia, High Risk1
- Cancer1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.